Skip to main content
Erschienen in: World Journal of Urology 5/2013

Open Access 01.10.2013 | Original Article

Urinary tract infections and post-operative fever in percutaneous nephrolithotomy

verfasst von: Jorge Gutierrez, Arthur Smith, Petrisor Geavlete, Hemendra Shah, Ali Riza Kural, Marco de Sio, José H. Amón Sesmero, András Hoznek, Jean de la Rosette, On behalf of the CROES PCNL Study Group

Erschienen in: World Journal of Urology | Ausgabe 5/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Purpose

To review the incidence of UTIs, post-operative fever, and risk factors for post-operative fever in PCNL patients.

Materials and methods

Between 2007 and 2009, consecutive PCNL patients were enrolled from 96 centers participating in the PCNL Global Study. Only data from patients with pre-operative urine samples and who received antibiotic prophylaxis were included. Pre-operative bladder urine culture and post-operative fever (>38.5°C) were assessed. Relationship between various patient and operative factors and occurrence of post-operative fever was assessed using logistic regression analyses.

Results

Eight hundred and sixty-five (16.2%) patients had a positive urine culture; Escherichia coli was the most common micro-organism found in urine of the 350 patients (6.5%). Of the patients with negative pre-operative urine cultures, 8.8% developed a fever post-PCNL, in contrast to 18.2% of patients with positive urine cultures. Fever developed more often among the patients whose urine cultures consisted of Gram-negative micro-organisms (19.4–23.8%) versus those with Gram-positive micro-organisms (9.7–14.5%). Multivariate analysis indicated that a positive urine culture (odds ratio [OR] = 2.12, CI [1.69–2.65]), staghorn calculus (OR = 1.59, CI [1.28–1.96]), pre-operative nephrostomy (OR = 1.61, CI [1.19–2.17]), lower patient age (OR for each year of 0.99, CI [0.99–1.00]), and diabetes (OR = 1.38, CI [1.05–1.81]) all increased the risk of post-operative fever. Limitations include the use of fever as a predictor of systemic infection.

Conclusions

Approximately 10% of PCNL-treated patients developed fever in the post-operative period despite receiving antibiotic prophylaxis. Risk of post-operative fever increased in the presence of a positive urine bacterial culture, diabetes, staghorn calculi, and a pre-operative nephrostomy.

Introduction

Percutaneous nephrolithotomy (PCNL) is the preferred method of removing renal calculi, particularly among the patients with a large or complex stone burden, resulting in stone free rates exceeding 90% [1, 2]. However, up to one-third of PCNL patients experience some peri-operative complications [3], the most common being fever secondary to a urinary tract infection (UTI), which occurs in 21–39.8% of the patients [4, 5]. Although the vast majority of post-PCNL temperature elevations are transient in nature, between 0.3 and 9.3% of patients can develop potentially life-threatening sepsis [4, 5]. The pathogenesis of UTIs after PCNL treatment is thought to begin with bacterial release from surgical manipulation and/or fragmentation of calculi or the introduction of bacteria via the nephrostomy tract [6]. Additionally, numerous patient characteristics and operative factors have been reported to augment the risk of infection post-PCNL, including positive pre-operative urinary culture, female sex, operative time, use of a nephrostomy tube, and prior PCNL procedures among others [58]. Unfortunately, the associations between any one factor and the post-PCNL risk of UTIs have been largely inconsistent across studies.
The European Association of Urology (EAU) guidelines suggest that all potential PCNL patients with infection stones, recent history of UTI, or positive urine culture should receive antibiotic therapy before the stone-removing procedure and it be continued for least 4 days post-operatively [9]. Furthermore, antibiotic prophylaxis may also reduce the risk of post-PCNL infectious complications among the patients with sterile urine and non-infectious calculi [10]. However, antibiotic prophylaxis fails to completely eliminate the risk of infection associated with the PCNL procedure [5, 7].
The Clinical Research Office of the Endourological Society (CROES) is responsible for organizing, structuring, and facilitating a global network for endourological research [11]. Their first major initiative involved the development of the PCNL Global Study, a prospective global database of indications and outcomes of PCNL. The aims of the current investigation were to review the incidence of UTIs and to assess the risk factors associated with the occurrence of post-operative fever among the PCNL patients.

Materials and methods

The organizational details of the CROES PCNL Global Study have been previously reported including the operative procedure [12]. Between November 2007 and December 2009, 5,803 consecutive patients treated over a 1-year period at each of 96 participating global centers were included in the PNCL Global Study. Patients eligible for inclusion in the study were all those who were candidates for PCNL treatment as the primary indication or following the failure of previous treatment. For the current analysis, only patients with a pre-operative urine culture and antibiotic prophylaxis were included.
Bladder urine samples were obtained prior to surgical procedure at the discretion of the treating physician, and subsequently tested for the presence of bacterial cultures. Regardless of the presence of a positive urine culture, all patients received antibiotic prophylaxis according to individual protocols at each center. The presence of a post-operative fever of ≥38.5°C as a proxy for infection was assessed according to the established protocols at each participating center. Institutional review board approval was obtained if required; otherwise, the lead investigator was responsible for ensuring the quality of clinical data collected.

Statistical analysis

The relationship between various patient and operative factors and the occurrence of post-operative fever was assessed using univariate and multivariate logistic regression analyses. Backward selection of variable was performed to optimize the model. The level of significance was defined as P < 0.05. All analyses were performed using SPSS version 16.0.

Results

Characteristics of all 5803 patients included in the Global PCNL Study, the intra-operative details of the PCNL procedure, and the post-operative treatment outcomes have been previously described elsewhere [12]. A total of 5,354 (92.2%) patients with available pre-operative urine samples and who received antibiotic prophylaxis were included in the current analysis. Patient characteristics are shown in Table 1.
Table 1
Patient characteristics
Parameter
Mean (SD)
Age (years)
49.2 (15.6)
Body Mass Index (kg/m2)
26.7 (5.2)
Stone burden (mm2)
375.9 (236.6)
 
N (%)a
Sex
 Male
3,015 (56.4)
 Female
2,334 (43.6)
Diabetes
719 (13.5)
ASA score
 ASA 1
2,861 (54.1)
 ASA 2
1,813 (34.3)
 ASA 3
568 (10.7)
 ASA 4
49 (0.90)
Pre-operative nephrostomy
421 (8.0)
Staghorn stone
1,357 (27.2)
Positive pre-operative urine cultures
865 (16.2)
aComplete variable sets analyzed
Overall, 865 (16.2%) patients assessed were found to have a positive urine culture. The frequency of the different micro-organisms found in the pre-operative urine cultures of PCNL patients is outlined in Table 2. Escherichia coli was the most common micro-organism found, and the frequency of micro-organisms was consistent across the four continents assessed with the exception of North America where the incidence of positive cultures was higher. The frequency of E. Coli was considerably lower in North America (20.9%) as compared with the other continents (range 39.4–57.4%). Conversely, the frequency of a mixed colony sample was notably higher in North America (19.4%) in comparison with the other continents (range 1.7–10.6%).
Table 2
Frequency of micro-organisms in positive urine cultures of percutaneous nephrolithotomy patients
 
Total sample
N (%)
Asia
N (%)
Europe
N (%)
North America
N (%)
South America
N (%)
Prevalence of positive cultures
16.2% (865/5,354)
16.0% (209/1,308)
12.6% (387/3,071)
30.4% (211/695)
20.7% (58/280)
Prevalence of negative cultures
83.8% (4,489/5,354)
84.0% (1,099/1,308)
87.4% (2,685/3,071)
69.6% (483/695)
79.3% (222/280)
Total positive culture
865 (100.0)
209 (100.0)
387 (100.0)
211 (100.0)
58 (100.0)
Isolated micro-organism
 Escherichia coli
350 (40.5)
120 (57.4)
153 (39.4)
44 (20.9)
33 (56.9)
 Proteus spp.
95 (11.0)
11 (5.3)
50 (13.0)
28 (13.3)
6 (10.4)
 Klebsiella spp.
65 (7.5)
25 (12.0)
32 (8.3)
8 (3.8)
0 (0.0)
 Others
45 (5.2)
4 (1.9)
22 (5.7)
19 (9.0)
0 (0.0)
 Enterococcus spp.
71 (8.2)
10 (4.8)
39 (10.0)
18 (8.5)
4 (6.9)
 Staphylococcus spp.
62 (7.2)
11 (5.3)
18 (4.7)
30 (14.2)
3 (5.2)
 Enterobacter spp.
21 (2.4)
8 (3.8)
8 (2.1)
4 (1.9)
1 (1.7)
 Pseudomonas spp.
69 (8.0)
16 (7.7)
24 (6.2)
19 (9.0)
10 (17.2)
 Mixed
87 (10.0)
4 (1.8)
41 (10.6)
41 (19.4)
1 (1.7)
Others include the following micro-organisms: Alcaligenes spp., Serratia spp., Lactobacilli spp., Citrobacter spp., Providencia spp., Aerococcus spp., Corynebacter spp., Aeromonas spp., Acinetobacter spp., Morganella spp., Candida spp., and Streptococcus spp.
A mixed colony contained a positive culture with more than one organism
Of the 5,313 PCNL patients who had data on both pre-operative urine culture and post-operative body temperature, 550 (10.4%) patients had developed a fever. Table 3 provides the proportion of patients experiencing a fever according to the type of micro-organism found pre-operatively in their urine. Of note, 8.8% of patients with negative urine cultures prior to treatment developed a fever post-PCNL, in contrast to 18.2% of patients with positive urine cultures. Nevertheless, the prevalence of fever among those with a positive urine culture varied markedly depending on which micro-organisms were found in their urine cultures, from a low of 9.7% among those with Staphylococcus spp. to a high of 23.8% among those with Enterobacter spp.
Table 3
Proportion of patients experiencing post-operative fever according to urine culture
 
Fever
N (%)
No fever
N (%)
Total negative culture
394 (8.8)
4,062 (91.2)
Total positive culture
156 (18.2)
701 (82.8)
Isolated micro-organism
 Escherichia coli
71 (20.3)
279 (79.7)
 Proteus spp.
18 (19.4)
75 (80.6)
 Klebsiella spp.
15 (23.1)
50 (76.9)
 Others
7 (15.9)
37 (84.1)
 Enterococcus spp.
10 (14.5)
59 (85.5)
 Staphylococcus spp.
6 (9.7)
56 (90.3)
 Enterobacter spp.
5 (23.8)
16 (76.2)
 Pseudomonas spp.
14 (20.6)
54 (79.4)
 Mixed
10 (11.8)
75 (88.2)
Others include the following micro-organisms: Alcaligenes spp., Serratia spp., Lactobacilli spp., Citrobacter spp., Providencia spp., Aerococcus spp., Corynebacter spp., Aeromonas spp., Acinetobacter spp., Morganella spp., Candida spp., and Streptococcus spp.
A mixed colony contained a positive culture with more than one organism
Table 4 depicts the relationship between various patient and intra-operative factors and the risk of post-PCNL fever, as assessed by univariate and multivariate analyses. In univariate analysis, a longer operation time for each additional minute, positive pre-operative urine culture, a staghorn calculus, residual stones, pre-operative presence of a nephrostomy, and a diagnosis of diabetes all predicted a greater likelihood of post-operative fever. In multivariate analysis, after controlling for all other factors, a positive urine culture, staghorn calculus, pre-operative presence of a nephrostomy, lower patient age, and diabetes were all associated with an increased risk of post-operative fever.
Table 4
Factors associated with post-operative fever among percutaneous nephrolithotomy patients
 
Univariate
Multivariate
OR
95% CI
P value
OR
95% CI
P value
Female sex
1.12
0.94–1.34
0.193
0.92
0.75–1.12
0.389
Patient age (years)
1.00
0.99–1.00
0.184
0.99
0.99–1.00
0.022
Diabetes
1.28
1.0–1.63
0.046
1.38
1.05–1.81
0.021
Positive urine culture
2.26
1.85–2.77
<0.001
2.12
1.69–2.65
<0.001
Pre-operative nephrostomy
1.77
1.34–2.34
<0.001
1.61
1.19–2.17
0.002
Operation time (mins)
1.00
1.00–1.01
<0.001
1.00
1.00–1.00
0.055
Staghorn calculus
1.88
1.56–2.28
<0.001
1.59
1.28–1.96
<0.001
Residual stone
1.47
1.21–1.78
<0.001
1.16
0.92–1.45
0.203
Post-operative nephrostomy
1.45
1.00–2.09
0.048
1.26
0.85–1.88
0.249
Prednisone treatment
1.71
0.86–3.38
0.125
1.75
0.83–3.69
0.142
With the exception of patient age and operation time, all other variables were coded as dichotomous

Discussion

Fever secondary to a UTI is one of the most common sequelae of PCNL, occurring in 21–39.8% of patients [4, 5]. Interestingly, only 10.4% of the sample in the current study experienced a post-operative fever. A number of factors may explain the wide variation in the incidence of post-PCNL fever across studies. First, the temperature cut-off used to define a fever varies between studies; while a temperature of >38.5°C was used in the current study, others have used a temperature of >38.0°C [8], ≥38.0°C [5], or did not specify a temperature cut-point [4]. Indeed, in one study [13], the proportion of PCNL patients who experienced a post-operative fever of >38.0°C and >38.5°C was 28.8 and 16.7%, respectively. Secondly, the time between PCNL and subsequent temperature assessment may also influence the prevalence of fever reported in a given study. For example, Draga et al. [5] found that while 39.8% of patients had developed a fever within 24 h of PCNL, this rate fell to just 13.0% when assessed beyond 24 h post-operatively.
Despite the fact that all patients in the current study received antibiotic prophylaxis, 18.2% of those with a positive pre-operative urine culture and 8.8% of those with sterile urine culture developed a post-operative fever. A previous study has indicated that 1 week of ciprofloxacin prophylaxis prior to PCNL significantly reduced the risk of urosepsis [10]. Nevertheless, in agreement with prior studies [5, 7, 8], our findings support the notion that antibiotic prophylaxis fails to completely eliminate the risk of infection associated with the PCNL procedure. Either bacterial resistance to antibiotic treatment [14] or the administration of an inappropriate antibiotic for the bacterial culture present in the upper urinary tract [5] may explain this apparent failure.
While 16.2% of patients in our database had a positive pre-operative bladder urine culture, others have previously reported rates ranging from 4.1 [8] to 53.6% [5]. Of the PCNL patients with a positive urine culture in the current study, E. coli was the most commonly isolated micro-organism, accounting for 40.5% of positive cultures. This finding is in agreement with prior studies of UTI patients, where E. coli was the predominant bacterial pathogen found in bladder urine [15], but contrast with those of Mariappan et al. [16] who found a mixed bacterial colony to be far more common than E. coli alone in the bladder urine of a small sample of PCNL patients (<20 vs. >60%, respectively). Interestingly enough, the authors reported that E. coli represented over 60% of positive cultures of pelvic urine in the same patients. Our results also illustrated significant geographic-dependant variation in the bladder urine cultures of PCNL patients. For example, a mixed colony accounted for 1.7% of positive cultures among the patients from South America, but 19.4% among the patients from North America. Conversely, E. coli was the only micro-organism in 20.9 and 57.4% positive urine cultures of North American and Asian PCNL patients, respectively.
While some have criticized the value of pre-operative bladder urine culture in predicting post-operative infection and associated complications [6, 16], our data clearly illustrate that a positive culture is associated with a twofold risk of fever in the post-operative period. These findings are consistent with those of Aghdas and colleagues [8], who found a higher rate of fever post-PCNL among the patients with positive versus negative urine culture (50 vs. 33.3%, respectively). Additionally, results of the current investigation suggest that the risk of post-operative fever among the patients with a positive urine culture depends on the specific micro-organisms found in their urine. Specifically, post-operative fever was reported in 9.7–14.5% of the patients whose urine cultures consisted of Gram-positive micro-organisms (Staphylococcus spp. and Enterococcus spp.) but in 19.4–23.8% of the patients with Gram-negative micro-organisms (e.g., E. coli, Enterobacter spp., and others).
In addition to a positive urine culture, the logistic regression analysis in the current study uncovered a number of risk factors for post-PCNL fever. First, in agreement with the established association between staghorn or struvite calculi and risk of UTIs caused by urea-splitting bacteria [17], the presence of staghorn calculi was shown to independently increase the risk of fever by approximately 60%. This finding contrasts with prior studies with relatively small sample sizes which failed to find an association between staghorn calculi and symptoms of infection post-PCNL [5, 8]. Diabetic PCNL patients were also at significantly greater risk of developing a fever in the post-operative period, not surprisingly given that diabetes profoundly elevates the risk of developing UTIs [18]. In agreement with at least one prior study [8], the use of a nephrostomy tract was also associated with a 60% increased risk of post-operative fever. Although the reason for this finding is unclear, some authors have suggested that a nephrostomy tract may simply be used during more complicated cases, rather than directly affecting the risk of infection [8]. While it is well established that women are generally at greater risk of UTIs in comparison with men [19], we found no relationship between the sex and risk of fever post-PCNL, a finding corroborated by others [5, 16]. Finally, in agreement with numerous prior efforts [5, 8, 16], once other factors were accounted for in multivariate analysis, the duration of the operation was not a significant predictor of post-operative fever risk.
In regard to study limitations, it has been argued that fever alone cannot be used as an indicator of systemic infection. Rao et al. [20] reported that while 74% of the PCNL patients in their study developed post-operative fever, only 41% had endotoxemia. Others suggest that transient post-PCNL fever is often caused by a bodily reaction to the operation and resorption of an hematoma and does not accurately represent post-PCNL sepsis [5]. Although bladder urine was used to assess the UTIs in the current study, some argue that bacterial culture of bladder urine is often a poor indicator of cultures found in upper urinary tract urine and in renal calculi [16]. Finally, the details of antibiotic treatment and fever assessment were not available, and thus, any potential variability in these factors could not be accounted for in the analysis.

Conclusion

The study showed that approximately 10% of patients developed fever post-PCNL despite receiving antibiotic prophylaxis. Predictors of post-operative fever include positive urine culture, diabetes, the presence of a staghorn calculus, and the pre-operative use of a nephrostomy tube.

Acknowledgments

The Global PCNL Study was supported by an unrestricted educational grant from Olympus.

Conflict of interest

No competing financial interests exist.

Open Access

This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Gynäkologie

Kombi-Abonnement

Mit e.Med Gynäkologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
1.
Zurück zum Zitat Skolarikos A, Alivizatos G, de la Rosette JJ (2005) Percutaneous nephrolithotomy and its legacy. Eur Urol 47:22PubMedCrossRef Skolarikos A, Alivizatos G, de la Rosette JJ (2005) Percutaneous nephrolithotomy and its legacy. Eur Urol 47:22PubMedCrossRef
2.
Zurück zum Zitat Osman M, Wendt-Nordahl G, Heger K et al (2005) Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int 96:875PubMedCrossRef Osman M, Wendt-Nordahl G, Heger K et al (2005) Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int 96:875PubMedCrossRef
3.
Zurück zum Zitat Tefekli A, Ali Karadag M, Tepeler K et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53:184PubMedCrossRef Tefekli A, Ali Karadag M, Tepeler K et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53:184PubMedCrossRef
4.
Zurück zum Zitat Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899PubMedCrossRef Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899PubMedCrossRef
5.
Zurück zum Zitat Draga RO, Kok ET, Sorel MR et al (2009) Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol 23:921PubMedCrossRef Draga RO, Kok ET, Sorel MR et al (2009) Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol 23:921PubMedCrossRef
6.
Zurück zum Zitat Mariappan P, Tolley DA (2005) Endoscopic stone surgery: minimizing the risk of post-operative sepsis. Curr Opin Urol 15:101PubMedCrossRef Mariappan P, Tolley DA (2005) Endoscopic stone surgery: minimizing the risk of post-operative sepsis. Curr Opin Urol 15:101PubMedCrossRef
7.
Zurück zum Zitat Dogan HS, Sahin A, Cetinkaya Y et al (2002) Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 16:649PubMedCrossRef Dogan HS, Sahin A, Cetinkaya Y et al (2002) Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 16:649PubMedCrossRef
8.
Zurück zum Zitat Sharifi Aghdas F, Akhavizadegan H, Aryanpoor A et al (2006) Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect 7:367CrossRef Sharifi Aghdas F, Akhavizadegan H, Aryanpoor A et al (2006) Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect 7:367CrossRef
10.
Zurück zum Zitat Mariappan P, Smith G, Moussa SA et al (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98:1075PubMedCrossRef Mariappan P, Smith G, Moussa SA et al (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98:1075PubMedCrossRef
11.
Zurück zum Zitat De la Rosette J (2009) A platform for global endourological research. J Endourol 23:551CrossRef De la Rosette J (2009) A platform for global endourological research. J Endourol 23:551CrossRef
12.
Zurück zum Zitat De la Rosette J, Assimos D, Desai M et al (2011) The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: indications, complications, and outcomes in 5803 patients. J Endourol 25:11PubMedCrossRef De la Rosette J, Assimos D, Desai M et al (2011) The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: indications, complications, and outcomes in 5803 patients. J Endourol 25:11PubMedCrossRef
13.
Zurück zum Zitat Cadeddu JA, Chen R, Bishoff J et al (1998) Clinical significance of fever after percutaneous nephrolithotomy. Urology 52:48PubMedCrossRef Cadeddu JA, Chen R, Bishoff J et al (1998) Clinical significance of fever after percutaneous nephrolithotomy. Urology 52:48PubMedCrossRef
14.
Zurück zum Zitat Farrell DJ, Morrissey I, De Rubeis D et al (2003) A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 46:94PubMedCrossRef Farrell DJ, Morrissey I, De Rubeis D et al (2003) A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 46:94PubMedCrossRef
15.
Zurück zum Zitat Barrett SP, Savage MA, Rebec MP et al (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359PubMedCrossRef Barrett SP, Savage MA, Rebec MP et al (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359PubMedCrossRef
16.
Zurück zum Zitat Mariappan P, Smith G, Bariol SV et al (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610PubMedCrossRef Mariappan P, Smith G, Bariol SV et al (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610PubMedCrossRef
17.
Zurück zum Zitat Healy KA, Ogan K (2007) Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am 34:363PubMedCrossRef Healy KA, Ogan K (2007) Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am 34:363PubMedCrossRef
18.
Zurück zum Zitat Ronald A, Ludwig E (2001) Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 17:287PubMedCrossRef Ronald A, Ludwig E (2001) Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 17:287PubMedCrossRef
19.
Zurück zum Zitat Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5SPubMedCrossRef Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5SPubMedCrossRef
20.
Zurück zum Zitat Rao PN, Dube DA, Weightman NC (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955PubMed Rao PN, Dube DA, Weightman NC (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955PubMed
Metadaten
Titel
Urinary tract infections and post-operative fever in percutaneous nephrolithotomy
verfasst von
Jorge Gutierrez
Arthur Smith
Petrisor Geavlete
Hemendra Shah
Ali Riza Kural
Marco de Sio
José H. Amón Sesmero
András Hoznek
Jean de la Rosette
On behalf of the CROES PCNL Study Group
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0836-y

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.